You haven't searched anything yet.
Fate Therapeutics is seeking a highly motivated Senior Scientist with expertise in immunology, immune cell therapy and/or autoimmune diseases to join our Clinical Translation group. The successful candidate is a collaborative individual with the ability to work in a highly matrixed environment and across multidisciplinary teams. They will support/lead biomarker assay development and implementation, data analysis from clinical samples, and execute experiments to support translational strategies in early phase clinical trials across Fate’s iPSC derived NK and T cell platforms. The ideal candidate will demonstrate clear and professional verbal and written communication skills, capable of presenting scientific data to multidisciplinary teams both internally and with external collaborators. This is a full-time position located at our corporate headquarters in San Diego, CA.
\nResponsibilities
The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time.
Equal Employment Opportunity
Fate Therapeutics, Inc. is an equal opportunity employer. We value diversity and are committed to creating an inclusive environment for all employees.
Privacy Notice
To learn about how Fate collects and uses job application information, please visit Fate's online Privacy Notice.
About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s effector cell pipeline includes multiplexed-engineered, iPSC-derived natural killer (NK) cell and T-cell product candidates, which incorporate novel synthetic controls of cell function, such as chimeric antigen receptors (CARs) to target tumor-associated antigens and are intended to deliver multiple mechanisms of therapeutic importance to patients including in combination with well-established cancer therapies. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.
Full Time
$145k-177k (estimate)
04/28/2024
06/27/2024
fatetherapeutics.com
San Diego, CA
100 - 200